David Smith

OMX Ventures LLC (OMX Ventures) is a venture capital firm founded in 2020. The firm is headquartered in Lincolnshire, Illinois.

RubrYc Therapeutics, Inc. develops antibody therapy applications. Its products include RubrYc Discovery Engine, through which people can decode protein interactions through the integration of data and biological science. The company was founded in 2017 and is headquartered in San Carlos, CA.

QuantaLife, Inc. operates as a biotechnology company. It develops and manufactures products based on nucleic acid testing concept for the life science research, clinical molecular diagnostics, personalized medical care and industrial markets. The company was founded by Kevin Dean Ness, Benjamin Hindson, Christopher T. Blisard and William Wayne Colston Jr. in 2008 and is headquartered in Boulder, CO.

Lawrence Livermore National Laboratory provides nuclear testing services. The Laboratory's security needs include countering the proliferation of weapons of mass destruction and strengthening homeland security against the terrorist use of such weapons. The company was founded in 1952 and is headquartered in Livermore, CA.

Purigen Biosystems, Inc. engages in extracting, enriching and quantifying DNA and RNA from biological samples. The company was founded in 2012 by Amy Hiddessen, Klint Rose and Juan Santiago and is headquartered in Pleasanton, CA.

Rheonix, Inc. operates microfluidic platform for the molecular diagnostics industry. It is committed to improving standards of care by making molecular diagnostics available to more people, in more places, more often. The firm's platform performs fully automated, complex molecular assays in an easy to use and economical format on the Rheonix CARD cartridge. The company was founded by Greg Galvin in 2007 and is headquartered in Ithaca, NY.

Transverse Medical, Inc. develops Point-Guard, a cerebral embolic protection device. The firm specializes in cerebral embolic protection, transcatheter aortic valve, surgical aortic valve and medical device development. The company was founded in 2011 and is headquartered in Golden, CO.

Vanquish Oncology, Inc. operates as a drug development company. It focused on targeting molecular defects in specific cancer cells to create personalized oncology therapeutics for unmet and underserved cancer markets. The company was founded by Paul J. Hergenrother, Mike Handley and Ted Tarasow and is headquartered in Champaign, IL.

The Scripps Research Institute is a private, non-profit research organizations that performs basic biomedical research in molecular & cellular biology, chemistry, immunology and neuroscience. They receive the majority of its funding from federal agencies such as the National Institutes of Health. The organization also partners with pharmaceutical companies and is affiliated with the Scripps hospital group. The organization was founded in 1955 and is headquartered in La Jolla, California.

iCarbonX engages in the provision of digital health records by storing genomic, and medical and daily health data services. The firm offers individualized health analysis and prediction of health index through advanced data mining and machine analysis technologies. The company was founded on by Haoli, Yingrui Li, Jun Wang, and Chun Wu on October 28, 2015 and is headquartered in Shenzhen, China.

Vitalium Capital Partners LP is an investment advisory firm founded in 2021. The private company is based in Stamford, CT. The company provides investment advice to its clients.

Ralexar Therapeutics, Inc. operates as an pharmaceutical company that develops topical and systemic therapies. The company was founded in January 2014 and is headquartered in Wayne, PA.

Rodin Therapeutics, Inc. develops first in class therapeutics for cognitive disorders. The company was founded by Bruce Booth in 2013 and is headquartered in Cambridge, MA.

Oppilan Pharma Ltd. operates as a biotechnology company. The company is headquartered in Cambridge, the United Kingdom.

Catalytic IP, Inc. is a digital research platform built for life sciences companies. Its products include Catalytic Corporate and Alliance Platform. The company was founded by Scott Sacane and is headquartered in Charleston, SC.

Third Point Ventures LLC (Third Point Ventures) is a venture capital subsidiary of Third Point LLC founded in 1995 by Daniel Seth Loeb. The firm is headquartered in Menlo Park, California.

Akarna Therapeutics Ltd. develops novel small molecule therapeutics. It offers non-bile acid FXR agonist, a therapeutic for the treatment of nonalcoholic steatohepatitis and fatty-liver diseases. The company was founded by Raju Mohan in 2014 and is headquartered in Cambridge, the United Kingdom.

Channel Medsystems, Inc. engages in the development of healthcare technologies. The company was founded by Daniel Rogers Burnett and Brian Michael Neil on March 15, 2013 and is headquartered in Emeryville, CA.

Lyric Pharmaceuticals, Inc. operates as a clinical-stage pharmaceutical company. The firm develops novel gastrointestinal therapeutics for unmet medical needs in the hospital settings. The company was founded by David Wurtman and M. Scott Harris in 2013 and is headquartered in South San Fancisco, CA.

Sestina Bio LLC operates a platform for automated synthetic biology. It provides technology centric, R&D platform to provide cutting edge solutions to sustainably feed and clothe. The firms approach is to integrate tools for genome editing, single cell biology, and machine learning to transform ability to engineer and harness biological function. The company was founded by William Wayne Colston, Jr. and is headquartered in Pleasanton, CA.

Clinverse, Inc. provides automated financial management technology solutions for clinical trials. The firm’s products include ClinPay, ClinDebit and ClinViz. The company was founded on July 10, 2008 by Stephen Ayala and Tim S. Immel and is headquartered in Durham, NC.

Matterworks, Inc. is a biotechnology company that specializes in metabolomics screening. The company is based in Somerville, MA. The company was founded by Jack Geremia and Mimoun Cadosch Delmar, with Jack Geremia serving as the CEO since incorporation.

Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC.

Critical Path Institute is a nonprofit organization established in 2005 as a public and private partnership with the FDA's Critical Path Initiative program. The non-profit company is based in Tucson, AZ, and operates from Ireland with additional staff in multiple other locations. The company's mission is to catalyze the development of new approaches that advance medical innovation and regulatory science, accelerating the path to a healthier world. The company orchestrates the development of drug development tools through an innovative, collaborative approach to the sharing of data and expertise, and accelerate the pace and reduce the costs of medical product development by building consensus among the participating institutions. The company was founded in 2005 by Raymond L. Woosley, Glenn C. Rice. Daniel M. Jorgensen has been the CEO of the company since 2022.

CR Certification Corp. provides online portals for archiving, beready training, and cardioready training. The private company is based in Malvern, PA. The company also offers assistance in selecting automated external defibrillators (AEDs) through their ultimate buyer's guide and resource center pages.

Cardioready, Inc. supplies cardiac equipment to organizations to reduce the impact of sudden cardiac arrest. The private company is based in Wallingford, PA.

Shoefitr, Inc. helps online shoppers to find the correct size and best fitting shoes. Its technology is used on retailer's websites to assist online shoppers and will be the basis for a comparative shopping site that allows customers to search and compare shoes by fit. The company was founded in 2010 by Matt Wilkinson, Nick End and Breck Fresen and is headquartered in Pittsburgh, PA.

TARA Biosystems, Inc. develops organ-on-a-chip platform. It focuses on cardiac toxicology, heart failure drug discovery and personalized cardiology. The company was founded by Misti Ushio, Milica Radisic, Yimu Zhao, Gordana Vunjak-Novakovic, Kacey Ronaldson, Boyang Zhang and Blake Stevens on October 22, 2014 and is headquartered in New York, NY.